share_log

Roth MKM Upgrades Orthofix Medical to Buy, Raises Price Target to $20

Benzinga ·  May 8 17:49

Roth MKM analyst Jason Wittes upgrades Orthofix Medical (NASDAQ:OFIX) from Neutral to Buy and raises the price target from $15 to $20.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment